Isoprostanes: An overview and putative roles in pulmonary pathophysiology

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 6 24-6, 2001, Pages

  Janssen, L J ^a,b  

^a ST JOSEPH S HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Arachidonic acid; Endothelium; Inflammation; Lipid peroxidation; Oxidative stress; Platelet; Smooth muscle

Indexed keywords

BIOCHEMICAL MARKER; FREE RADICAL; ISOPROSTANE; MEMBRANE LIPID; REACTIVE OXYGEN METABOLITE;

CELL TYPE; CHEMICAL STRUCTURE; LIPID PEROXIDATION; LUNG ALVEOLUS CELL; LUNG ENDOTHELIUM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0034990522     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.6.l1067     Document Type: Review

References (174)

1. Total synthesis of 17,17,18,18-d4-iPF2α-VI and quantification of iPF2α-VI in human urine by gas chromatography/mass spectrometry
2. Effects of recombinant human superoxide dismutase on tumor necrosis factor-induced lung injury in awake sheep
3. 2-isoprostane) metabolites in human urine and plasma
4. 2α, in rabbit lung in situ
5. Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy
6. Thromboxane and pulmonary morphometry in the development of the pulmonary hypertensive response to group B streptococcus
7. Reactive oxygen species and airway inflammation
8. 2α
9. 2α: An index for oxidative injury via free radical catalysed lipid peroxidation
10. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity
11. F2-isoprostane generation in isolated ferret lungs after oxidant injury or ventilated ischemia
12. Identification of extremely reactive γ-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts
13. 2α-III and an oxidation product of γ-linolenic acid
14. 2 and genistein differentially modulate protein tyrosine phosphorylation, endothelial morphology, and monolayer barrier function
15. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS
16. 2 mediates pulmonary hypertension after cardiopulmonary bypass in the rabbit
17. 2) in vivo
18. Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway
19. 2α
20. Oxidant stress correlates with impairment of tissue oxygenation in patients with pulmonary hypertension
21. Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina
22. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of receptors and their subtypes
23. 2α, isoprostane in cystic fibrosis
24. 2 muscarinic receptors to ERK MAP kinases and caldesmon in colonic smooth muscle
25. 2α, on the contractility of the human myometrium in vitro
26. 2α is increased in hypercholesterolemia
27. 2α and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation
28. 2α: Specific analysis of an isoeicosanoid as an index of oxidant stress in vivo
29. 2α generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo
30. In vitro antioxidant neuroprotective activity of BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation
31. 2 adrenergic presynaptic inhibition
32. 2α)
33. Intestinal effects of isoprostanes: Evidence for the involvement of prostanoid EP and TP receptors
34. Isoprostanes, novel eicosanoids that produce nociception and sensitize rat sensory neurons
35. Elevated plasma 8-isoprostanes: Marker of asthma severity
36. Phosphorylation of caldesmon by p21-activated kinase. Implications for the Ca(2+) sensitivity of smooth muscle contraction
37. 2-isoprostane receptors on rat vascular smooth muscle cells
38. Vascular smooth muscle actions and receptor interactions of 8-iso-prostaglandin E2, an E2-isoprostane
39. 2-isoprostane, on endothelin-1 release
40. 2
41. 2
42. Postinjury thromboxane receptor blockade ameliorates acute lung injury
43. 2α: A possible marker of lipid peroxidation in term infants with severe pulmonary disease
44. EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine
45. 2α levels are elevated in individuals with non-insulin dependent diabetes mellitus
46. Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis
47. Low-dose angiotensin II increases free isoprostane levels in plasma
48. Isoleukotrienes are biologically active free radicals products of lipid peroxidation
49. 2-induced derangements of pulmonary artery endothelial cell barrier function
50. 2α in the airways of human subjects
51. LPS-induced airway hyperreactivity in mice is partly mediated by a non-cyclooxygenase-derived TP-receptor agonist
52. The participation of the cyclooxygenase pathway and oxidative stress in lipopolysaccharide-induced airway and vascular hyperreactivity in the perfused mouse lung
53. 2-isoprostane excretion rate and diurnal variation in human urine
54. Effect of the isoprostanes, 8-iso prostaglandin E2 and 8-iso prostaglandin F2 alpha on the rabbit lung in vivo
55. Oxidant stress in sled dogs subjected to repetitive endurance exercise
56. Isoprostanes: Free radical-generated prostaglandins with constrictor effects on cerebral arterioles
57. 2α) in immature pig periventricular brain microvessels
58. Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies
59. Isoprostanes: Generation, pharmacology, and roles in free radical-mediated effects in the lung
60. Excitation-contraction coupling in pulmonary vascular smooth muscle involves tyrosine kinase and Rho kinase
61. 2- and superoxide-induced relaxations in canine trachealis
62. Excitatory and inhibitory actions of isoprostanes in human and canine airway smooth muscle
63. Vasoconstrictor actions of isoprostanes via tyrosine phosphorylation and Rho kinase in human and canine pulmonary vascular smooth muscles
64. Cyclooxygenase and lipoxygenase inhibition by BW-755C reduces acrolein smoke-induced acute lung injury
65. 2-induced contraction in pulmonary artery
66. Analysis of the pulmonary hypertensive effects of the isoprostane derivative, 8-iso-PGF2alpha, in the rat
67. Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary artery
68. 2 production in human isolated pulmonary artery smooth muscle cells: Concomitant and differential release
69. Release of isoprostanes by human pulmonary artery in organ culture: A cyclo-oxygenase and nitric oxide dependent pathway
70. 2α in isolated perfused rat lung
71. 2α, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro
72. 2α
73. Cellular activation of thromboxane receptors
74. 2α in vitro and in vivo via cyclooxygenases
75. 2 on platelets
76. 2α
77. 2α on isolated rat aorta
78. 2α in the hypoxic rat heart
79. 2α
80. 2α-III, induce cardiomyocyte hypertrophy: Differential activation of downstream signaling pathways
81. 2σ on retinal vessels
82. 2α-VI, in human urine
83. The influence of isoprostanes on ADP-induced platelet aggregation and cyclic AMP-generation in human platelets
84. 2 and acute hypoxic pulmonary arterial pressure
85. 2, on the platelet thromboxane/endoperoxide receptor in humans and rats: Additional evidence for the existence of a unique isoprostane receptor
86. 2α in pericardial fluid of patients with heart failure: A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure
87. 2-isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal cultures
88. 2α, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats
89. The role of reactive oxygen and nitrogen species in the response of airway epithelium to particulates
90. 2α, is accumulated in coronary arteries isolated from patients with coronary heart disease
91. 2α on retinal circulation in diabetic and non-diabetic rats
92. Role of vasoactive mediators in primary and secondary pulmonary hypertension
93. 2α increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO
94. Cyclooxygenase inhibition aggravates ischemia-reperfusion injury in the perfused guinea pig heart: Involvement of isoprostanes
95. 2/prostaglandin endoperoxide receptors in porcine carotid arteries
96. 2-isoprostane concentration in probable AD
97. 8-Isoprostane, a new biomarker of oxidative stress in asthma
98. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases
99. 2α from guinea-pig lung in vitro
100. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis
101. 2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite
102. 2-isoprostanes) are formed in situ on phospholipids
103. 2-isoprostanes) in carbon tetrachloride hepatotoxicity: An animal model of lipid peroxidation
104. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo
105. 2-isoprostanes) in smokers
106. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism
107. 2α, is formed in vivo
108. Free radical-induced generation of isoprostanes in vivo: Evidence for the formation of D-ring and E-ring isoprostanes
109. 2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist
110. 2-isoprostanes) in the hepatorenal syndrome
111. 2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism
112. The isoprostanes: Current knowledge and directions for future research
113. 2) is formed in vivo
114. Thromboxane inhibition and monocrotaline-induced pulmonary hypertension in rats
115. Prostanoid receptors: Structures, properties, and functions
116. 2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factors
117. 3-isoprostanes during peroxidation of eicosapentaenoic acid
118. 2α) in human and porcine lymphatics and lymph
119. 2α in human atherosclerotic vascular tissue
120. 2α induces airflow obstruction and airway plasma exudation in vivo
121. Effects of some isoprostanes on the human umbilical artery in vitro
122. 2
123. 1 from α-linoleic acid in plants
124. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients
125. 2-isoprostane formation
126. Improved bronchial anastomiotic healing secondary to maintenance or restoration of bronchial arterial circulation by microsurgical techniques
127. IPF2alpha-I: An index of lipid peroxidation in humans
128. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress
129. 2α by human monocytes: Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2
130. Enhanced lipid peroxidation in hepatic cirrhosis
131. Localization of distinct F2-isoprostanes in human atherosclerotic lesions
132. Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha
133. 2α
134. 2α is not mediated by thromboxane receptor isoforms
135. Vitamin E suppresses isoprostane generation in vivo and reduced atherosclerosis in ApoE-deficient mice
136. The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide
137. Hydrogen peroxide contracts human airways in vitro: Role of epithelium
138. 2 excretion in pigs
139. 2-isoprostanes in rats
140. 4/E4-neuroprostanes) in vivo from docosahexaenoic acid
141. Modulation of oxidant stress in vivo in chronic cigarette smokers
142. 2α in acute coronary angioplasty: Evidence for exidant stress during coronary reperfusion in humans
143. 2α in humans
144. The isoprostanes: A perspective
145. Isolevuglandin-protein adducts in humans: Products of free radical-induced lipid oxidation through the isoprostane pathway
146. Influence of isoprostanes on vasoconstrictor effects of noradrenaline and angiotensin II
147. 2α, in some isolated smooth muscle preparations
148. 2α levels in healthy subjects
149. 2α by lipopolysaccharide-activated J774 macrophages
150. 2α
151. Effect of eicosanoid inhibition on the development of pulmonary edema after acute lung injury
152. 2α in humans
153. Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle
154. 2α is a potent contractor of human peripheral lymphatics
155. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II
156. 2α in the decidua basalis of women with preeclampsia
157. Oxidant damage during and after spaceflight
158. 2 receptors
159. Thromboxane receptor blockade improves oxygenation in an experimental model of acute lung injury
160. 2α production by alveolar macrophages exposed to hyperoxia
161. 2α, in pulmonary oxygen toxicity
162. Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids
163. Platelet activation and lipid peroxidation in patients with acute ischemic stroke
164. Characterization of signal transduction events stimulated by 8-epi-prostaglandin(PG)F2 alpha in rat aortic rings
165. Severe VA/Q mismatch in perfused lungs evoked by sequential challenge with endotoxin and E. coli hemolysin
166. 2α excretion in man
167. 2 synthase
168. Nitro blue tetrazolium inhibits but does not mimic hypoxic vasoconstriction in isolated rabbit lungs
169. Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction
170. 2 receptors in human platelets
171. 2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells
172. 2-III)
173. Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury
174. 2/prostaglandin endoperoxide receptors in aorta